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Su-Anne Eng and Sheila Nathan*
Faculty of Science and Technology, School of Biosciences and Biotechnology, National University of Malaysia, Bangi,
Malaysia
The tropical pathogen Burkholderia pseudomallei requires long-term parenteral
antimicrobial treatment to eradicate the pathogen from an infected patient. However,
the development of antibiotic resistance is emerging as a threat to this form of
treatment. To meet the need for alternative therapeutics, we proposed a screen of natural
products for compounds that do not kill the pathogen, but in turn, abrogate bacterial
virulence. We suggest that the use of molecules or compounds that are non-bactericidal
(bacteriostatic) will reduce or abolish the development of resistance by the pathogen. In
this study, we adopted the establishedCaenorhabditis elegans-B. pseudomallei infection
model to screen a collection of natural products for any that are able to extend the
survival of B. pseudomallei infected worms. Of the 42 natural products screened, only
curcumin significantly improved worm survival following infection whilst not affecting
bacterial growth. This suggested that curcumin promoted B. pseudomallei-infected
worm survival independent of pathogen killing. To validate that the protective effect
of curcumin was directed toward the pathogen, bacteria were treated with curcumin
prior to infection. Worms fed with curcumin-treated bacteria survived with a significantly
extended mean-time-to-death (p < 0.0001) compared to the untreated control. In
in vitro assays, curcumin reduced the activity of known virulence factors (lipase and
protease) and biofilm formation. To determine if other bacterial genes were also regulated
in the presence of curcumin, a genome-wide transcriptome analysis was performed on
curcumin-treated pathogen. A number of genes involved in iron acquisition and transport
as well as genes encoding hypothetical proteins were induced in the presence of
curcumin. Thus, we propose that curcuminmay attenuateB. pseudomallei bymodulating
the expression of a number of bacterial proteins including lipase and protease as well
as biofilm formation whilst concomitantly regulating iron transport and other proteins of
unknown function.
Keywords: Burkholderia pseudomallei, Caenorhabditis elegans, curcumin, antibiotic resistance,
bacterial attenuation
Introduction
Burkholderia pseudomallei is the causative agent of the tropical disease, melioidosis, which is
endemic in Southeast Asia and northern Australia (Wiersinga et al., 2006). Melioidosis accounts
for the high overall mortality in northeast Thailand and is reported to be the third leading cause of
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death from infectious diseases after human immunodeficiency
virus (HIV)-AIDS and tuberculosis (Limmathurosatkul et al.,
2010). Despite growing efforts to develop immunoprophylaxis
treatment for melioidosis (Hara et al., 2009; Patel et al., 2011;
Choh et al., 2013; Silva and Dow, 2013), currently there is no
vaccine available for clinical use. Thus, treatment of melioido-
sis is still solely dependent on a lengthy course of antibiotics.
Nevertheless, B. pseudomallei is becoming increasingly resistant
to a diverse group of antimicrobials including third generation
cephalosporins whilst quinolones and aminoglycosides have no
reliable effect (Puthucheary and Sam, 2012). For example, two
important antibiotic candidates in melioidosis treatment are cef-
tazidime and amoxicillin-clavulanic acid and cases of resistance
have been reported in recent years (Wuthiekanun et al., 2011).
Therefore, therapeutic options are limited and the difficulty in
achieving sterilization is not fully understood. Hence, there is an
urgent need for new alternative treatments for this disease.
To alleviate the worldwide problem of multidrug resistant
(MDR) bacteria such as the carbapenem-resistant Enterobacteri-
acea (Kumarasamy et al., 2010; Zilberberg and Shorr, 2013), new
strategies have been developed to reduce the impact of antibiotic
resistance. As the search for new antibiotics is proving to be a
major problem, an alternative strategy being pursued globally is
the search for new anti-infectives. Unlike traditional antibiotics
that are either bacteriostatic or bactericidal, anti-infectives are
known to target bacterial virulence (Clatworthy et al., 2007; Papa
et al., 2013; Sarabhai et al., 2013) or alternatively, improve host
immunity (Hamill et al., 2008; Nijnik, 2013; Kong et al., 2014b).
Inhibition of virulence should prevent the onset of infection, per-
sistence and damage to the host without threatening bacterial
survival, thus reducing selection pressure toward the develop-
ment of antibiotic resistance (Clatworthy et al., 2007; Cegelski
et al., 2008).
The versatile nematode, Caenorhabditis elegans, was selected
as the host model for this study. C. elegans has been widely used
as a tool to elucidate host-pathogen interactions (Tan et al., 1999;
Garsin et al., 2001; Lee et al., 2011). Many of the bacterial viru-
lence factors identified to be crucial in the killing of C. elegans
were also required for pathogenesis in mammals hence promot-
ing the importance of the worm as a tool in anti-virulence drug
discovery (Moy et al., 2006; Adonizio et al., 2008). An impor-
tant resource of molecules in the search for new drugs against
human diseases is natural products (Newman and Cragg, 2012).
The availability of these natural products and their derivatives has
enabled the identification of potential candidate anti-infectives
toward clinical pathogens using the C. elegans infection model
platform (Moy et al., 2006; Kong et al., 2014a). In addition, the
in vivo whole animal screen allows simultaneous assessment of
drug pharmacokinetics and toxicity.
In this study, we utilized the established C. elegans - B. pseu-
domallei infection model (O’Quinn et al., 2001; Gan et al., 2002;
Lee et al., 2013) as a screening tool to assess a collection of natural
products as potential anti-infectives toward B. pseudomallei. This
screen identified a natural compound, curcumin, as a positive hit
based on its ability to prolong the lifespan of infected worms.
Curcumin is a polyphenol extracted from Curcuma longa. It is
commonly used in cuisine and folk medicine especially in South
and Southeast Asian countries. Anecdotal evidence has proposed
that curcumin exhibits a number of beneficial properties such
as antioxidant, anti-inflammatory, antiviral, antibacterial, anti-
fungal and anti-cancer activities (Aggarwal et al., 2007). Cur-
cumin is known to be antibacterial toward various pathogens
(Moghadamtousi et al., 2014) and this could be attributed to
the iron chelating property of curcumin that impedes bacterial
growth. However, in this study we observed continued survival
and growth of B. pseudomallei in the presence of curcumin.
Nevertheless, pretreatment of the bacteria with curcumin prior
to nematode infection resulted in enhanced survival of infected
worms proposing the selective action of curcumin on pathogen
virulence. Further transcriptome analysis was undertaken to pro-
vide more insight into the possible mode adopted by curcumin in
its role as a potential anti-infective agent against B. pseudomallei.
Materials and Methods
Bacterial Isolates and Nematode Strains
B. pseudomallei clinical isolates R15 (Lee et al., 2007), K96243
(Holden et al., 2004) and UM6 as well as Enterococcus faecalis
V583 were grown in BHI broth, Pseudomonas aeruginosa strain
PA14 in King’s B broth, Staphylococcus aureus strain NCTC83254
and methicillin-resistant S. aureus (MRSA) strain ATCC33591 in
Trypticase Soy (TS) media while Escherichia coli strain OP50 and
Salmonella typhimurium SL1344 were cultured in Luria Bertani
(LB) broth. All bacterial cultures were grown aerobically at 37◦C
overnight. The wild type C. elegans Bristol N2 (N2) and rrf-
3(pk1426);glp-4(bn2) strains were obtained from the Tan Labo-
ratory at Stanford University USA. The worms were maintained
on nematode growth medium (NGM) agar plates seeded with a
lawn of the standard laboratory food source, E. coli OP50. Age-
synchronization of the worms was conducted by the hypochlo-
rite treatment of gravid worms as described by Shapira and Tan
(2008). N2 worms were made sterile through RNAi knockdown
of the pos-1 gene (Tabara et al., 1999) by feeding the worms with
E. coli expressing double stranded RNA (dsRNA) directed against
pos-1. Both sterile N2 and rrf-3(pk1426);glp-4(bn2) worms were
grown at 25◦C until they reached the young adult stage before
they were used for infection.
Natural Products
A total of 42 natural products extracted from various plants
and marine extracts were used in this study. These products
were either obtained commercially or supplied by the Institute
for Pharmaceuticals and Neutraceuticals Malaysia (IPharm).
Preparation and the origin of samples UE-01-1 to UE-20 are
described in Kong et al. (2014a). Extracts UE-21 and UE-22
were purchased from Cosway Pte. Ltd while UE-23 and UE-24
were acquired from ONI Global Pte. Ltd. and Cambert Ptd.
Ltd., respectively. Information on the 42 natural products is
available in Supplementary Data 1. Stock solutions for all the
natural products were prepared in dimethyl sulfoxide (DMSO),
filtered with a 0.2µmmembrane filter and stored at−20◦C until
further use.
Anti-Infective Screening
Screening of natural products was performed based on the
protocol by Moy et al. (2006) with some modifications.
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Firstly, the screening medium comprising of 90% M9 buffer,
10µg/mL cholesterol, 10% B. pseudomallei overnight culture and
200µg/mL natural extract was prepared and aliquoted into indi-
vidual wells (750µL) in a 24-well plate. Each extract was tested in
triplicate wells. Infection began when 10 pos-1 treated N2 young
adult worms were transferred into each well and the plate was
incubated at 25◦C without agitation. In control wells, B. pseu-
domallei was replaced with E. coli OP50 while the extract was
replaced with 1% DMSO. Worm survival was scored manually
throughout the assay. Worms were scored as dead when they did
not respond to gentle probing with a platinum worm picker. An
extract was considered a positive hit if it resulted in an average
worm survival of>50% in at least 2 out of 3 independent assays at
a point when 50% of the untreated worms survived the infection.
Determination of Antimicrobial Properties of
Positive Hits
Disc Diffusion Test
The disc diffusion assay was carried out according to the method
outlined by the Clinical and Laboratory Standards Institute
(CLSI) M2-A9 (CLSI, 2006). The inoculum was prepared by
diluting a B. pseudomallei overnight culture to OD595 = 0.5 (10
8
cfu/mL). A total of 100µL of the inoculumwas spread onMueller
Hinton agar using glass beads. Each positive hit (20mg/mL) was
impregnated into individual sterile filter paper discs (Whatman
No. 1, 5mm) and left to dry overnight. Tetracycline (200µg/mL)
was used as the positive control while DMSO was used as the
negative control. Dried impregnated discs were placed on the B.
pseudomallei lawn and incubated at 37◦C for 20 h. The forma-
tion of a clear zone of inhibition around the disc indicated the
presence of antimicrobial activity for the extract.
Broth Microdilution Antimicrobial Test
The observed antimicrobial property of positive hits was con-
firmed through the broth microdilution minimum inhibitory
concentration (MIC) test (Wiegand et al., 2008). Positive hits
were diluted twofold from 500 to 0.24µg/mL in a 96-well plate
and an inoculum of 106 cfu/mL B. pseudomallei was added into
each well. This test was conducted using the anti-infective screen-
ingmedium (90%M9 buffer+ 10% BHI broth) in order tomimic
the assay conditions above. The plate was incubated at 37◦C for
20 h. The same concentrations of tetracycline and DMSO were
included as the positive and negative controls, respectively. The
MIC of a positive hit was defined as the lowest concentration
where no visible bacterial growth was observed. The minimum
bactericidal concentration (MBC) was determined by spreading
the culture from each well onto agar plates. The lowest concen-
tration with no bacterial growth on an agar plate was deemed the
MBC value for the particular hit.
Determination of curcumin antimicrobial effects on B. pseu-
domalleiwas conducted in standard medium (BHI broth) similar
to the broth microdilution method above. Concentrations of cur-
cumin ranging from 0.6 to 1200µM were tested along with their
vehicle DMSO and tetracycline as controls. After incubation, cul-
tures from each concentration were serially diluted, spotted on
agar, incubated and the bacterial colony forming units (CFU)
were enumerated. However, for the effect of curcumin on P.
aeruginosa, E. coli OP50, S. typhimurium, E. faecalis, S. aureus
and MRSA, CFU was not counted. Instead, cultures were spotted
directly onto agar plates and incubated. The bacterial growth
in each spot was visually compared to their respective DMSO
control. The bacteria were considered susceptible to curcumin if
there was a decrease in the visible growth when compared to the
vehicle DMSO.
C. elegans Survival Assay
The liquid based survival assay was performed in the same man-
ner as the anti-infective screen but with minor modifications.
The pos-1 treated N2 young adult worms were replaced with
30 sterile rrf-3(pk1426);glp-4(bn2) young adult worms. The rrf-
3(pk1426);glp-4(bn2) worms carry a glp-4 temperature sensitive
mutation which results in germline-deficient worms when grown
at 25◦C (Beanan and Strome, 1992). Therefore, rrf-3(pk1426);glp-
4(bn2)worms were maintained at 16◦C to produce gravid worms
and subjected to hypochlorite treatment to obtain eggs. The eggs
were seeded on NGM agar and grown to sterile young adult
worms at 25◦C that were then used for the infection assay.
Alive and dead worms were scored every 4 h post-infection.
Each extract was assayed in triplicate wells corresponding to
a total of 90 worms. In control wells, extract was replaced
with DMSO whereas B. pseudomallei was replaced with E. coli
OP50.
We used a modified survival assay to investigate the effect of
curcumin on the pathogenicity of B. pseudomallei in C. elegans.
Firstly, B. pseudomallei was cultured overnight in the presence of
curcumin (50µM, 100µM or 543µM) at 37◦C. The curcumin-
treated cultures were then centrifuged at 4000 g for 10min at
4◦C. The supernatant was removed and the bacterial cell pel-
let was resuspended with fresh BHIB broth. The washing step
was repeated to minimize curcumin content. The cell suspen-
sion was then used in the preparation of assay medium, which
comprised only of 90% M9 buffer, 10% curcumin-treated culture
and 10µg/mL cholesterol without any further addition of cur-
cumin into the assay medium. Infection began when 30 sterile
rrf-3(pk1426);glp-4(bn2) young adult worms were added into the
wells. For the negative control, B. pseudomallei was treated with
DMSO instead of curcumin.
Colony Forming Unit (CFU) Assay
In vivo bacterial counts were determined according to the
method of Ooi et al. (2012). At each time point, 10 live worms
infected with 50µM curcumin-treated bacteria were randomly
picked and briefly anesthetized in 25mM Lev. The worms were
washed twice in 200µl antibiotic cocktail comprising 25mM Lev
and 500µg/ml kanamycin followed by incubation for at least
45min to completely kill bacterial cells associated with the worm
cuticle. Next, the worms were washed three times with 200µl of
25mM Lev to eliminate the killed bacteria and residual antibi-
otic. During the last washing step, the Lev was removed, leaving
about 5µl in the tube. Prior to adding 50µl 1% Triton X (Sigma-
Aldrich, X100), the worms were enumerated and then homoge-
nized with a motorized pestle. Serial dilutions were performed on
the worm lysates. Briefly, 10µl of the worm lysate was spotted on
Ashdown agar supplemented with 100µg/ml Cm using the drop
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plate method with modifications. Colonies were counted after
incubating the plates at 37◦C for 48 h. Average colony numbers
obtained from visually separate colonies were used for statistical
analysis. Bacterial CFU per worm was calculated using the for-
mula: (average colony number × dilution factor × 55µl worm
lysate)/(10µl worm lysates plated × number of worms). Three
independent replicates were performed for the experiment. The
phrase “55µl worm lysate” (50µl 1% Triton X + 5µl Lev con-
taining the worms) refers to the total worm lysate of which 10µl
was used for plating.
The Effect of Curcumin and Ethylene Glycol
Tetraacetic Acid (EGTA) on B. pseudomallei
Replication
An overnight B. pseudomallei culture was diluted 100 fold in
fresh broth supplemented with curcumin (50µM, 100µM or
543µM) or EGTA (5mM or 10mM). The subculture was there-
after incubated shaking (250 rpm) at 37◦C. At 2-hourly intervals,
CFU counts were determined and a growth curve was plotted.
The doubling time (g), was calculated from the exponential phase
of the growth curve using the formula: g = t log 2/(log Nt – log
N0) where N0 = number of CFU at a point during log phase,
Nt = number of CFU at a different time point during log phase
and t = time interval betweenN0 andNt . DMSO (0.1%) was used
as the control.
The Effect of Curcumin on B. pseudomallei
Virulence Factors
Hemolysin Test
To determine if curcumin affects B. pseudomallei hemolysin,
curcumin-treated (50µM, 100µM or 543µM) B. pseudomallei
overnight culture was streaked on 5% rabbit blood agar and incu-
bated at 37◦C for 24 h. During the preparation of the agar, the
same amount of curcumin was added while the agar was still in
molten state. As a control, B. pseudomallei was cultured in the
presence of DMSO (0.1%, 0.2% or 1.0%) and streaked on DMSO
supplemented blood agar. After 24 h incubation, the presence and
type of hemolysis was recorded.
Lipase Test
The effect of curcumin on B. pseudomallei lipase was determined
using Rhodamine B-olive oil agar (Kouker and Jaeger, 1987). B.
pseudomallei was co-cultured with 50µM, 100µM or 543µM
curcumin overnight and subsequently spotted on Rhodamine
B-olive oil agar supplemented with the same concentration of
curcumin and then incubated at 37◦C for 48 h. As a control, B.
pseudomallei was cultured in the presence of DMSO (0.1%, 0.2%
or 1.0%) and streaked on DMSO supplemented Rhodamine B-
olive oil agar. After 48 h, the plates were observed under UV light
(350 nm). Lipase activity was indicated by orange-red fluorescent
colonies.
Protease Test
The effect of 50µM curcumin on B. pseudomallei protease was
determined using 3% skimmilk agar (Oxoid, UK). The overnight
curcumin-treated bacterial culture was spotted on skimmilk agar
supplemented with 50µM curcumin and incubated at 37◦C for
48 h. As a control, B. pseudomalleiwas cultured with 0.1%DMSO
and spotted on 0.1% DMSO supplemented skim milk agar. After
48 h incubation, the formation of a halo was observed.
The Effect of Curcumin on B. pseudomallei
Biofilm Production
The biofilm assay was conducted according to the protocol of
Koh et al. (2013). Firstly, the known high biofilm producer B.
pseudomalleiUM6 was cultured overnight with 50µM curcumin
at 37◦C. The overnight culture was diluted using fresh broth (BHI
broth + 50µM curcumin) to OD595 = 1 to obtain a standard-
ized inoculum. For the negative control, 50µM curcumin was
replaced with 0.1%DMSO. The standardized inoculums (200µL)
were dispensed into 8 wells of a 96-well plate and incubated at
37◦C for 48 h. Uninoculated BHI broth was included as the blank
control. Following incubation, the wells were washed with 1X
phosphate buffered saline (PBS) to remove non-adherent bac-
teria. Thereafter, the wells were fixed with 200µL 99% (v/v)
methanol for 15min and air-dried at room temperature. The
wells were then stained with 200µL filtered 2% crystal violet
for 5min. The excess stain was washed with water and the wells
were air-dried. The stain bound bacterial cells were solubilized
with 200µL of 95% (v/v) ethanol and the released stain was
measured at 570 nm using a microplate reader (Sunrise, Tecan,
Switzerland).
Whole Transcriptome Analysis
The transcriptome analysis was conducted using the
B. pseudomallei array and protocol previously described by
Chieng et al. (2012). In brief, B. pseudomallei was cultured for
10 h (log-phase) with 50µM curcumin or 0.1% DMSO as control
at 37◦C. Total RNA was extracted using Trizol, purified with
Qiagen’s RNeasy Mini Kit and on-column DNase I digestion was
performed. The concentration, quality, and integrity of all RNA
samples were analyzed using the Nanodrop R© ND-1000 and
Agilent 2100 Bioanalyser. Only RNA samples with a RIN value
of ≥ 9 were selected for the next step. The RNA samples were
polyadenylated using the A-plus™ Poly (A) Polymerase Tailing
Kit (Epicentre). cDNA synthesis, labeling, and hybridization
were performed according to the Agilent one-color microar-
ray protocol. The polyadenylated RNA samples were reverse
transcribed to cRNA, amplified, and labeled using Agilent’s
Low Input Quick Amp Labelling Kit. Next, the labeled cRNA
samples were purified with the RNeasy Mini Kit and subjected
to Nanodrop R© ND-1000 reading. Only purified samples with
a yield >1.65µg and specific activity of >9.0 pmol Cy3 per µg
cRNA were used for hybridization. The purified labeled cRNA
samples (800 ng) were fragmented using the Agilent Fragmen-
tation Buffer. This step was conducted at 60◦C for 30min. After
that, the fragmentation reaction was stopped by cooling the
samples on ice for 1min followed by the addition of Agilent 2×
Hi-RPM Hybridization Buffer. The hybridization samples were
centrifuged at 13000 g for 1min at room temperature. A total of
40µL of each of the hybridized samples was loaded onto each
array on the probe slide. The array was hybridized at 65◦C for
17 h. Washing steps were done with the Agilent GE Wash Buffer
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according to the manufacturer’s protocol. The arrays were then
scanned on the Agilent Technologies Scanner.
Spot intensities and quality control features of each array
were extracted using the Agilent Feature Extraction Software.
The processed signals were filtered and normalized with BRB-
ArrayTools (http://linus.nci.nih.gov). The resultant data were
subjected to TIGR-MeV software for Significance Analysis of
Microarray (SAM) analysis in which a two class unpaired analysis
was performed and genes with a false discovery rate (FDR)< 0.01
and fold change ≥ 1.5 were defined as significantly differentially
expressed. Functional classifications were carried out based on
Comprehensive Microbial Resources (CMR) annotations (www.
cmr.jcvi.org). Gene function enrichment analysis was performed
against the DAVID 6.7 database (http://david.abcc.ncifcrf.gov/
home.jsp) using the Fisher Exact test with Benjamini and
Hochberg multiple testing correction (p < 0.05). The microarray
result was validated using quantitative real-time PCR (qRT-PCR)
analysis. qRT-PCR was conducted with the iScript One-Step
RT-PCR kit with SYBR Green according to the manufacturer’s
instructions (Bio-Rad Laboratories) on the Bio-Rad iCycler. The
gene BPSL2758 (glyA) that encodes for hydroxymethyltransferase
was used as the reference as it did not show any significant
changes in expression from the microarray experiment.
Quantitative Estimation of Siderophore
The ability of curcumin to induce B. pseudomallei siderophore
production was confirmed by using the Chrome Azurol S-liquid
assay (CAS) (Schwyn and Neilands, 1987). The CAS assay detects
a change in color from the blue CAS-iron complex to orange free
dye when the bound iron is competitively chelated by a higher
iron affinity siderophore from the complex. B. pseudomallei was
cultured under the same conditions as that for the transcriptome
experiment (10 h log phase) with either 50µM curcumin or
vehicle 0.1% DMSO at 37◦C. The cultures were then centrifuged
at 4000 g for 10min at 4◦C. The supernatants were filtered
with a 0.2µm membrane filter to remove residual bacterial
cells. The supernatants (100µL) were then transferred into 5
wells in a 96-well plate, representing 5 technical replicates. An
equal amount of CAS assay solution (Schwyn and Neilands,
1987) containing 4mM 5-sulfosalicylic acid was added into each
well. The 5-sulfosalicylic acid acts as a CAS shuttle solution
to increase the rate of iron exchange. Two reference blanks
(BHI broth+ 50µM curcumin and BHI broth+ 0.1% DMSO)
without the addition of bacteria culture were included in
the assay. Upon addition of the CAS assay solution, the
plate was measured at 630 nm after equilibrium was reached
(approximately 1 h). The relative percentage of siderophore
produced by both untreated and curcumin-treated B.
pseudomallei was then calculated and compared.
Statistical Analysis
Results from worm survival assays were analyzed using the
Kaplan-Meier nonparametric survival analysis in Statview R©
5.0.1 (SAS Institute, Inc). The data were presented as mean ±
standard deviation (SD) of a representative from at least two
independent experiments. The data from the rest of the assays
were expressed as mean ± standard error of the mean (SE)
from at least two independent assays. Statistical analyses were
performed using the unpaired, two-tailed Student’s t-test.
Results
Identification of Potential Anti-Infectives Using
the C. elegans - B. pseudomallei System
Based on previous studies, B. pseudomallei is able to infect
and kill C. elegans (O’Quinn et al., 2001; Gan et al., 2002;
Lee et al., 2013). Using this system, several possible virulence
determinants have been successfully elucidated (Gan et al., 2002;
Puah et al., 2014). In this study, we extended the utility of
the B. pseudomallei - C. elegans infection model to screen for
anti-infectives that rescue the worm from infection. With this
approach, we aimed to identify potential hits that attenuate the
bacterial virulence factors. Throughout the study, the B. pseu-
domallei R15 clinical isolate was used unless stated otherwise.
From the screen of 42 natural products, seven positive hits were
obtained (Figure 1). These positive hits were UE-08, UE-09, UE-
11, UE-14, UE-15, UE-18, and UE-21. These positive hits were
able to enhance the survival of infected worms exceeding 50%
survival at a point where half of the untreated worms succumbed
to infection.We also noted that treatment with a number of these
natural products resulted in lower worm survival when compared
to the untreated control. Testing of selected natural products on
E. coliOP50 fed worms indicated that these compounds are toxic
to the host. For example, UE-03-4 and UE-03-5 treated worms
killed the worms even in the absence of infection when compared
to the untreated control (data not shown).
The extended lifespan of infected worms in the presence of
these positive hits could be attributed to the possible antimi-
crobial property of the natural products toward B. pseudoma-
llei. However, we were only interested in potential extracts that
were not antimicrobial in nature to reduce the possibility of the
pathogen developing resistance to the selected hit(s). To delineate
the selected positive hits into those with or without antimicro-
bial activity toward B. pseudomallei, we performed the disc dif-
fusion and MIC tests. From the disc diffusion test, only one hit,
UE-08, formed a zone of inhibition around the disc (Figure 2).
The antimicrobial effect of all the positive hits was also deter-
mined through the broth microdilution MIC test. Again, only
UE-08 exhibited an MIC value of 250µg/mL and an MBC value
of 500µg/mL. This proposed that UE-08 enhanced the survival
of infected worms by reducing the number of infecting bacteria.
UE-08 is the crude extract of Curcuma longa. One of the well-
established active ingredients of C. longa is curcumin and in this
study, curcumin is represented by the positive hit UE-15. How-
ever, UE-15 did not show any anti-B. pseudomallei activity in
both tests. The antimicrobial activity of the crude extract could
be due to the existence of other components of C. longa such
as diarylpentanoids, monoterpenes, sesquiterpenes, diterpenes,
triterpenoids, alkaloid and sterols (Li et al., 2011). For example,
terpenoids from C. longa were reported to possess antibacterial
killing of various pathogens (Afzal et al., 2013). Thus, UE-08 was
omitted from further analysis.
A more stringent survival assay was performed on the
remaining positive hits utilizing a larger number of worms
Frontiers in Microbiology | www.frontiersin.org 5 April 2015 | Volume 6 | Article 290
Eng and Nathan Curcumin attenuates B. pseudomallei
FIGURE 1 | Natural products enhanced the survival of
B. pseudomallei infected worms. The chart above compares the
hits from the screen performed on 42 natural products (200µg/mL).
The data are plotted at the point where 50% of the untreated
worms survived the infection. Natural products resulting in survival
exceeding the untreated control were selected for further analysis.
Results are expressed as mean ± SE from at least two
independent assays.
FIGURE 2 | Antimicrobial property of positive hits toward
B. pseudomallei. (A) A clear zone of 30mm was formed for the positive
control (tetracycline) while no zone of inhibition was observed for the negative
control (DMSO). No inhibition zones were formed for UE-09 and UE-11
implying that they did not exert antimicrobial effect on the bacteria. (B) The
formation of a clear inhibition zone (9mm) around the disc indicated
susceptibility of the bacteria to UE-08.
and additional time points to verify the anti-infective activities.
Out of the positive hits tested, only UE-15 significantly
prolonged the lifespan of B. pseudomallei infected worms (p <
0.0001) when compared to the untreated control (Figure 3A).
The mean-time-to death (TDmean) of infected untreated worms
was 21.019 ± 0.975 h and this was extended to 24.938 ± 0.522 h
upon UE-15 treatment. As mentioned above, UE-15 is curcumin
(Figure 3B), a polyphenol component of C. longa. Tables 1, 2
summarize the data obtained for the C. elegans survival assays
and antimicrobial tests respectively.
Curcumin Rescues Worms from B. pseudomallei
Infection with a Mechanism Distinct from
Conventional Antibiotics
From the screen, we identified curcumin as a potential anti-
infective agent as it is capable of extending worm survival with-
out compromising bacteria viability. Nevertheless, we performed
further analysis to validate the observed antimicrobial effects.
Bacteria were cultured in the presence of different concentration
of curcumin and viable bacterial counts were enumerated. Cur-
cumin at concentrations between 0.6 and 600µMdid not signifi-
cantly reduce the number of CFU compared to the untreated bac-
teria (Figure 4A). At the higher concentration of 1200µM, we
are unable tomake any conclusion as the concentration of DMSO
(11.01%) used is itself antimicrobicidal (Ansel et al., 1969). Nev-
ertheless, the data allowed us to conclude that 543µM curcumin
(the concentration used in the screens) was not antimicrobial
toward B. pseudomallei. Tetracycline was used as the positive
control and it significantly reduced (p < 0.01–p < 0.0001)
the number of CFU at concentrations from 2.3µM onwards
(Figure 4A). The CFU data were used to plot growth curves for
two strains of B. pseudomallei, K96243 and R15, grown in the
presence of 50µM, 100µM or 543µM curcumin. No signifi-
cant difference in growth rates was observed when compared
to the untreated bacteria (Figure 4B). The doubling times cal-
culated for B. pseudomallei strain R15 cultured in increasing
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FIGURE 3 | UE-15 rescued C. elegans from B. pseudomallei
infection. (A) The survival curves for worms treated with the 200
µg/ml of the 6 positive hits. Treatment with UE-09, UE-11, UE-14,
UE-18, and UE-21 failed to enhance the survival of infected worms
whereas the addition of UE-15 extended the lifespan when compared
to the untreated worms. Graph shows the mean ± SD from a
representative of three independent assays. In a pair-wise analysis
using the log-rank test, differences between UE-15 treated and
untreated samples were significant (p < 0.0001). (B) Chemical structure
of UE-15 or curcumin, a polyphenol from C. longa.
TABLE 1 | The list of positive hits and their effects on the survival of B.
pseudomallei infected C. elegans.
Natural
product ID/
Treatment
Plant
species/
compound
Extraction
solvent
Mean % of
survival
(primary screen)
Mean time to death
(hours ± SD)
(secondary screen)
Untreated
(+DMSO)
50.00 21.019 ± 0.332
UE-08 C. longa Water 53.67 na
UE-09 Centella
asiatica
Water 64.67 20.678 ± 0.301
UE-11 Eurycoma
longifolia
Water 75.67 18.258 ± 0.227
UE-14 Emblica
officinalis
Water 51.33 18.511 ± 0.215
UE-15 Curcumin 94.33 24.938 ± 0.522*
UE-18 Silybum
eburneum
Water 53.00 20.202 ± 0.302
UE-21 Chorella 53.67 20.778 ± 0.318
na-The survival of UE-08 treated worms was not available as this compound was not
chosen for the secondary screen.
*p < 0.0001.
curcumin concentrations were 1.08 ± 0.07 h (50µM), 1.15 ±
0.18 h (100µM), and 1.26 ± 0.05 h (543µM) compared to 1.09
± 0.13 h for bacteria grown in the absence of curcumin. On the
other hand, the doubling times for the reference strain K96243
were 1.20 ± 0.11 h (50µM), 1.25 ± 0.04 h (100µM), and 1.23 ±
0.06 h (543µM) compared to 1.25± 0.08 h in the untreated bac-
teria. This confirmed that curcumin did not affect the growth of
B. pseudomallei.
TABLE 2 | The antimicrobial effect of positive hits against B. pseudomallei.
Natural
product ID/
Treatment
Plant
species/
compound
Diameter of
zone of
inhibition (mm)
MIC
(µg/mL)
MBC
(µg/mL)
Untreated
(+DMSO)
– – –
Tetracycline 30 0.49 >500
UE-08 C. longa 9 250 500
UE-09 C. asiatica – –
UE-11 E. longifolia – – –
UE-14 E. officinalis – – –
UE-15 Curcumin – – –
UE-18 S. eburneum – – –
UE-21 Chorella – – –
DMSO and tetracycline were used as negative and positive controls respectively.
- No visible reduction of growth was observed.
To determine if curcumin demonstrated antimicrobial activity
toward other pathogens, the antimicrobial assay was repeated on
three Gram-negative bacteria (E. coli OP50, P. aeruginosa, and
S. typhimurium) and three Gram-positive bacteria (E. faecalis,
S. aureus, and MRSA). The growth of E. coli OP50 (Figure 5A)
and E. faecalis (Figure 5B) were visibly reduced at 1200µM cur-
cumin. Furthermore, curcumin also affected the viability of both
S. aureus (Figure 5C) and MRSA (Figure 5D) at 600µM and
1200µM curcumin. Our results are in concordance with the
findings of Gunes et al. (2013) which reported the antibacterial
effects of curcumin on E. coli, E. faecalis, S. aureus, and MRSA.
Moreover, Kong et al. (2014a) also identified curcumin as a pos-
itive hit in a similar screen conducted on S. aureus in C.elegans
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FIGURE 4 | Curcumin exhibited no antimicrobial effect on B.
pseudomallei. (A) At concentrations ranging from 0.6µM to 600µM,
curcumin did not affect bacterial growth as reflected by the insignificant
decrease in CFU when compared to the untreated control. DMSO at a
concentration of 11.01% was antibacterial and prevented further analysis
with curcumin at 1200µM. The positive control, tetracycline, significantly
decreased the number of CFU from 2.3µM onwards. The bar chart
corresponded to mean ± SE from three independent assays. (B) Growing
B. pseudomallei in the presence of 50µM, 100µM, and 543µM curcumin
did not affect pathogen growth when compared to the untreated control. The
graph shows the mean ± SE from three independent assays. (C) Treatment
of B. pseudomallei with EGTA affected bacterial growth in a dose dependent
manner. At 5 mM EGTA, no significant reduction of growth was observed.
However, treatment with 10mM EGTA significantly restricted the growth of
B. pseudomallei when compared to the untreated control. The graph shows
the mean ± SE from two independent assays.
FIGURE 5 | Curcumin inhibited the growth of Gram negative and
positive bacteria. Antimicrobial effect of curcumin on (A) E. coli OP50, (B)
E. faecalis, (C) S. aureus, and (D)MRSA. At 1200µM curcumin, growth of (A)
E. coli OP50 and (B) E. faecalis was reduced when compared to the untreated
control. On the other hand, the growth of (C) S. aureus and (D)MRSA was
inhibited by 600µM curcumin and more prominent at 1200µM.
infection model. However, in that report, the enhanced worm
lifespan was an outcome of a reduced number of infecting
bacteria in the presence of curcumin. Although our study has
demonstrated a negative effect of curcumin on P. aeruginosa,
the antimicrobial outcome of curcumin has been widely reported
(Gunes et al., 2013; Moghadamtousi et al., 2014). In addition,
the inability of curcumin to affect S. typhimurium growth in
vitromirrors the finding that curcumin promotes S. typhimurium
proliferation (Marathe et al., 2010). Hence, we propose that,
whilst in general curcumin is able to inhibit bacterial growth, it
does not hinder B. pseudomallei growth. Thus, curcumin rescues
C. elegans from a B. pseudomallei infection using a mechanism
distinct from conventional antibiotics.
As mentioned above, anti-infectives are able to either
attenuate the pathogen or alternatively, strengthen host immu-
nity. In both the screening and infection assays, curcumin
was present in the growth medium. As such, we are unable
to determine how the compound exerted its ability to rescue
the infected worms. In this study, we were interested in pur-
suing anti-infectives that target bacterial virulence factors. To
address this, the survival assay was modified whereby B. pseu-
domallei was pre-treated with 50µM, 100µM or 543µM cur-
cumin overnight prior to nematode infection. Following the
overnight incubation, the curcumin-treated bacteria were pel-
leted, washed and resuspended in fresh BHIB broth. Curcumin
pre-treated bacteria resulted in significant extension of worm
survival when compared to worms infected with untreated bac-
teria (p < 0.0001) (Figure 6). The TDmean was highest when the
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bacteria were treated with 543µM curcumin: 43.910 ± 1.663 h
compared to 26.724 ± 0.642 h for the untreated control. The
TDmean for both 50µM and 100µM were comparable at 34.839
± 1.426 h and 33.194± 1.358 h, respectively. This suggested that
curcumin is able to attenuate B. pseudomallei most likely by tar-
geting its virulence factor(s). In addition, worms infected with
FIGURE 6 | Curcumin targets B. pseudomallei to rescue C. elegans
from infection. The chart above demonstrates worm survival following
pre-treatment of B. pseudomallei with curcumin where the lifespan of worms
was extended compared to the untreated control. The graph shows the mean
± SD from at least two independent assays. In a pair-wise analysis using the
log-rank test, differences between treatment and control were significant.
50µM curcumin-treated bacteria were homogenized and bacte-
rial counts were enumerated. Up to 12 h post infection, no signif-
icant difference was observed in bacterial intestinal colonization
when compared to worms fed with untreated bacteria. The bacte-
rial counts for worms infected with curcumin pre-treated bacteria
at 4, 8, and 12 h post-infection were 1.58 ± 0.37, 1.26 ± 0.10,
and 2.05 ± 0.26 log CFU/worm respectively whereas the bacte-
rial counts for the untreated controls were 1.18 ± 0.03, 1.19 ±
0.01, and 1.97± 0.19 log CFU/worm respectively.
Curcumin Attenuates Lipase, Protease and
Biofilm Formation
B. pseudomallei is known to secrete a number of virulence factors
such as protease, lipase, hemolysin (Cheng and Currie, 2005) and
the recently identified BLF-1 toxin (Cruz-Migoni et al., 2011). To
evaluate the role of curcumin on selected secreted factors, we con-
ducted in vitro biochemical tests on B. pseudomallei hemolysin,
lipase and protease. The activity of these selected factors was
monitored on blood agar, Rhodamine B-olive oil agar and skim
milk agar, respectively. The respective agar plates were supple-
mented with curcumin to enable continuous exposure of the
bacteria to curcumin throughout the assay period.
B. pseudomallei expresses the α and β classes of hemolysin.
α-hemolysin is more commonly found among isolates and dis-
plays weak cytolytic activity that is observable only around heavy
bacterial growth. On the other hand, β-hemolysin is produced
infrequently but results in a clear hemolytic zone around single
colonies (Ashdown and Koehler, 1990). B. pseudomallei R15
produced the more common α-hemolysin which partially lysed
FIGURE 7 | Effect of curcumin on B. pseudomallei virulence
factors. In the hemolysin test, α hemolysis occurred in both (A)
untreated and (B) curcumin-treated bacteria implying curcumin did not
target B. pseudomallei hemolysin. In the lipase test, the presence of
lipase is indicated by the presence of orange-red fluorescing colonies
under UV light. The orange-red fluorescence was stronger in the
untreated control (C) when compare to the curcumin-treated cells (D).
In the protease test, the formation of a large halo was observed in
untreated cells (E) whilst a much smaller halo was observed in
curcumin-treated bacteria (F). Biofilm formation was also reduced
following curcumin treatment (G,H). The bar chart represents mean ±
SD from two independent assays.
Frontiers in Microbiology | www.frontiersin.org 9 April 2015 | Volume 6 | Article 290
Eng and Nathan Curcumin attenuates B. pseudomallei
red blood cells (Figure 7A). This hallmark of α-hemolysis is indi-
cated by the presence of green colored biliverdin, a by-product
of hemoglobin breakdown. Treatment with curcumin did not
affect the activity of hemolysin as α-hemolysis still occurred
(Figure 7B).
In the lipase assay, we spotted untreated and curcumin-
treated B. pseudomallei on Rhodamine B-olive oil agar (Kouker
and Jaeger, 1987). Hydrolysis of olive oil by lipase produces
free fatty acids. Interaction of free fatty acids with Rhodamine
B produces orange-red fluorescence when viewed under UV
light. Figures 7C,D depict our observations for both curcumin-
untreated and curcumin-treated bacteria. Upon curcumin treat-
ment, the intensity of the orange-red fluorescence was lower
(Figure 7D) than the untreated control (Figure 7C). We also
observed that this loss of intensity is more pronounced at higher
concentrations of curcumin indicating that the effect of curcumin
on lipase is dose dependent.
Curcumin also affected the activity or expression of B. pseudo-
mallei protease. The principle of the skim milk agar assay is that
protease will digest the opaque casein in the agar into transparent
smaller peptides and amino acid resulting in the formation of a
halo. The untreated B. pseudomallei culture hydrolysed the milk
casein resulting in a clearly noticeable halo (Figure 7E). How-
ever, when the bacteria was grown in the presence of curcumin,
the formed halo was smaller in size (Figure 7F). The ability of
curcumin to inhibit protease activity has also been reported for
curcumin-treated P. aeruginosa PA01 (Rudrappa and Bais, 2008).
Curcumin is also known to interfere with biofilm formation
(Neelakantan et al., 2013; Packiavathy et al., 2014). Hence, we
extended our investigation to determine if this was true for B.
pseudomallei as well. As the R15 isolate is a poor biofilm producer,
we used the B. pseudomalleiUM6, a high biofilm producing strain
(Chin et al., under review). In the presence of 50µM curcumin,
biofilm formation was significantly reduced (p < 0.001) when
compared to the untreated control (Figures 7G,H).
Transcriptome Analysis Revealed Induction of
Genes Involved in Iron Acquisition and Transport
as Well as Hypothetical Proteins
The ability of curcumin to inhibit B. pseudomallei lipase and
protease as well as biofilm formation hinted at the possibil-
ity that more virulence determinants could be targeted by cur-
cumin. We therefore measured the global transcriptome expres-
sion levels of curcumin-treated B. pseudomallei and compared
them to the expression of untreated bacteria. We treated with
bacteria with 50µM curcumin as this concentration was suf-
ficient to rescue the infected worms (Figure 6) and also sup-
pressed lipase and protease activity in addition to biofilm
formation.
From the transcriptome analysis, we noted that cur-
cumin significantly regulated the expression of 88 genes
with 76 genes up-regulated and 12 genes down-regulated
(Supplementary Data 2). Functional classification of these genes
(Figure 8) showed that most of the induced genes were pro-
teins of unknown function, hypothetical proteins and transport
and binding proteins. Gene function enrichment analysis on the
induced genes based on the KEGG biochemical pathways showed
significant enrichment (p = 2.04×10−5) of ATP binding cassette
(ABC) transporters specifically involving iron transport. On the
other hand, no significant enrichment function was generated for
the 12 repressed genes. Thus, all further discussion is limited to
only the up-regulated genes.
Curcumin is a known iron chelator (Jiao et al., 2006), hence,
it was not surprising to note the induction of genes involved in
iron acquisition and transport (discussed below). A number of
studies have proposed that the therapeutic effects of curcumin
FIGURE 8 | Functional classification of curcumin regulated B.
pseudomallei genes. A total of 88 genes were differentially regulated by
curcumin with 76 genes up-regulated whilst 12 down-regulated. Bars
indicate number of genes in each group that were significantly regulated by
curcumin. Genes were divided into functional categories based on
Comprehensive Microbial Resources (CMR) annotations.
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TABLE 3 | Curcumin-induced ABC-related iron acquisition genes.
ABC System Allocrite Gene Gene Description
1 Malleobactin BPSL1779 Putative siderophore biosynthesis related ABC transport protein
2 Pyochelin BPSS0590 Probable ATP-binding component of ABC transporter
3 Ferric citrate or Ornibactin BPSL1781 Extracytoplasmic-function sigma-70 factor PvdS
Ferric citrate or Ornibactin BPSL1783 Putative iron transport-related exported protein
Ferric citrate or Ornibactin BPSL1784 Putative iron transport-related ATP-binding protein
4 Heme BPSS0240 Hemin ABC transport system, ATP-binding protein
Heme BPSS0241 Hemin ABC transport system, membrane protein
Heme BPSS0244 Exported heme receptor protein
5 Siderophore BPSS1029 tonB-family receptor
Siderophore BPSS1204 Iron transport receptor protein
Iron (III) BPSL1277 Putative ABC transport system, membrane protein (possibly iron-related)
Iron (III) BPSL1278 Putative ABC transport system, iron-binding exported protein
FIGURE 9 | The effect of curcumin on B. pseudomallei siderophore.
(A) The CAS solution changes color from blue to orange upon curcumin
treatment whereas the mixture for untreated control remained blue. (B) The
amount of siderophore detected was significantly higher in curcumin-treated
bacteria than in the untreated control. The bar chart represents mean ± SE
from two independent assays.
can be attributed to its iron chelating properties (Baum and Ng,
2004; Jiao et al., 2009). In our study, the addition of curcumin
led to reduced iron concentration in the growth media as a result
of the chelation. Our findings are similar to data presented by
Tuanyok et al. (2005) and Alice et al. (2006) whereby iron trans-
port related genes were up-regulated in iron-deficient growth
conditions. Iron is essential for the growth and development of
all pathogens. Under iron-restricted conditions, bacteria overex-
pressed genes responsible for iron uptake in order to maintain
viability (Tuanyok et al., 2005).
In Gram negative bacteria, transport of iron from the envi-
ronment into the cell is an active process that requires the TonB
system (Krewulak and Vogel, 2008). In brief, Gram negative
bacteria secrete siderophores, molecules with high affinity for
iron, to scavenge iron from the environment. The TonB sys-
tem drives a proton motive force from the cytoplasmic mem-
brane to TonB dependent transporters (TBDTs) located at the
outer membrane. The energized TBDTs then actively transfer
iron bound siderophores into the cell (Krewulak and Vogel,
2008). The TonB system is made up of three components: TonB,
ExbB, and ExbD. In B. pseudomallei, these proteins are encoded
by BPSS0368, BPSS0367, and BPSS0366 respectively. From our
analysis, all three genes were up-regulated following curcumin
treatment.
As mentioned earlier, functional enrichment analysis revealed
that the majority of the induced genes are ABC transporters.
We mapped our list of up-regulated genes to the previously
annotated B. pseudomallei ABC systems (Harland et al., 2007)
and noted that five of the ABC systems involved in iron acqui-
sition were induced. The identity of the induced genes (12)
corresponding to each system is presented in Table 3.
In addition to the TonB and ABC systems, we also observed
an enrichment of siderophore-related genes. This suggests an
increase in the biosynthesis of hydroxamate-type siderophores
such as malleobactin and ornibactin as well as a mixed
catecholate-hydroxamate pyoverdine corresponding to the over
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expressed BPSL1774-BPSL1787 cluster of genes. Within the
BPSS0581–BPSS0594 cluster involved in pyochelin synthesis, a
number of genes were also up-regulated, again, proposing the
bacterial response to the low-iron environment in the presence
of curcumin. We determined the amount of siderophore present
in the growth media after curcumin treatment with the quan-
titative CAS-liquid assay. The amount of siderophore detected
was significantly higher (p < 0.005) than the untreated control
(Figure 9).
As iron is crucial for the optimal function of oxygen transport
in living organisms, deprivation of iron will restrict cell growth
and replication (Tuanyok et al., 2005). However, we had earlier
noted that curcumin did not suppress the in vitro growth of B.
pseudomallei (Figures 4A,B). On the other hand, in the presence
of 5mM EGTA, another known iron chelator, no apparent dif-
ference in growth rates was observed between the EGTA treated
and untreated B. pseudomallei (Figure 4C). However, when the
bacteria were treated with 10mM EGTA, growth of both strains,
K96243 and R15, was significantly reduced (p < 0.01–p <
0.05) from 6 h onwards when compared to the untreated con-
trol (Figure 4C). This is as expected as noted above, iron is
essential for bacterial growth. For example, the addition of 2,2′-
dipyridyl (DIP), an iron chelator, inhibited the growth of bacte-
ria in a dose dependent manner (Eijkelkamp et al., 2011). This
proposed that unlike common iron chelators, curcumin acts in
a manner that is independent of a reduction in cell viability.
From the expression profile, we also observed that a number
of genes involved in energy production are overexpressed in
the presence of curcumin (Figure 8) proposing normal bacterial
metabolism. The products of five genes (BPSL1554, BPSL1782,
BPSL2469, BPSS0495, BPSS1855) that were induced may com-
pensate for the loss of energy production caused by the three
repressed genes (BPSL0247, BPSS0278, BPSS1744). Furthermore,
the BPSS0495 gene that encodes a nitroreductase family protein
was induced. The induction of this gene suggested that B. pseu-
domalleimay use alternative sources such as nitrogen to generate
energy. This idea is supported by the up-regulation of BPSS0369
that encodes bacterioferritin ferredoxin. The BPSS0369 gene is
located upstream of the bacterioferritin gene (bfr) encoding a 64
amino acid-residue protein identical to a region of NifU, a [2Fe-
2S] protein found in nitrogen-fixing bacteria (Tuanyok et al.,
2005).
Discussion
Melioidosis has long been associated with high morbidity and
mortality in endemic areas and requires protracted long-term
antibiotic treatment (Wiersinga et al., 2006). Emergence of
antibiotic resistant isolates (Wuthiekanun et al., 2011) demands
for an urgent need for new alternative treatments. Therefore, the
aim of our study was to search for anti-infectives that specifically
target bacterial virulence thus reducing selection pressure toward
resistance. Many studies have adopted a similar approach to dis-
rupt pathways related to virulence including inhibiting toxin
function, toxin delivery, regulation of virulence expression, bac-
terial adhesion and biofilm formation (Clatworthy et al., 2007;
de la Fuente-Nunez et al., 2013). In general, the B. pseudomallei
genome content is distributed over 2 chromosomes (chromo-
somes 1 and 2) that demonstrate significant functional partition-
ing. Chromosome 1 is associated with core functions such as cell
metabolism and growth while chromosome 2 carries more genes
required for accessory functions such as adaptation for survival
and virulence factors (Holden et al., 2004). Our transcriptome
data demonstrated that 62.5% (55 genes) of the differentially reg-
ulated genes are located in chromosome 2whilst 37.5% (33 genes)
are in chromosome 1. The data from this study suggests that the
anti-infective effect of curcumin targets more accessory functions
compared to functions related to cell proliferation.
In our study, we used the B. pseudomallei -C. elegans infection
model to screen a collection of natural products for any that res-
cued the worms from infection by means of attenuating bacterial
virulence. One of these products, curcumin, was able to enhance
worm survival without affecting bacterial survival. The approach
we adopted involved screening all the natural products or con-
stituent ingredients against the infected worms first, rather than
beginning the study with the antimicrobial screen, in an effort to
maximize our search for potential anti-infectives. Although some
products are deleterious to the bacteria, at sub-MIC concen-
trations, they may be good anti-infective candidates capable of
attenuating virulence factors (Rudrappa and Bais, 2008). Further-
more, the animal model screen would simultaneously allow us to
identify products that rescue the worm via modulating the host
immune response (Hamill et al., 2008; Easton et al., 2009). When
we pre-treated both host and B. pseudomallei with curcumin
prior to infection, we found that worm survival was enhanced
under experimental conditions proposing that curcumin affects
both host immunity (data not shown) and bacterial virulence
and/or survival (Figure 6).
Curcumin, also known as diferuloylmethane, is a polyphenol
derived from turmeric. Many beneficial characteristics of cur-
cumin such as antimicrobial, anticancer, and antioxidant have
been documented (Aggarwal et al., 2007). In recent years, cur-
cumin has also attracted interest for its ability to delay aging and
age-related diseases (Sikora et al., 2010; Liao et al., 2011). In our
study, different biochemical tests demonstrated that curcumin
affects B. pseudomallei lipase and protease. We also showed
that curcumin impedes biofilm formation. Studies have shown
that curcumin is anti-virulent toward various pathogens, mainly
attributable to its anti-quorum sensing (anti-QS) trait (Rudrappa
and Bais, 2008; Packiavathy et al., 2014). Bacterial QS systems reg-
ulate virulence especially the secretion of toxins and also biofilm
formation (Antunes et al., 2010).We hypothesized that curcumin
attenuates B. pseudomallei by inhibiting the QS mechanism. We
went on to test this hypothesis by measuring the global gene
expression in curcumin-treated bacteria.
Unexpectedly, the transcriptome analysis did not reflect the
reduction in B. pseudomallei secretion of lipase and protease or
biofilm formation. Expression of genes corresponding to these
virulence factors and those involved in QS were not regulated.
This may be a result of analysis on the bacteria at different
phases of growth in the various experiments. Whilst the bacte-
ria used in the C. elegans survival assays and biochemical tests
were treated for 24–48 h, a 10-h log phase curcumin-treated cul-
ture was used to harvest the RNA for transcriptome analysis.
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B. pseudomallei is known to express different sets of genes during
distinct growth phases (Rodrigues et al., 2006). In our analysis,
we found that most of the up-regulated genes encode proteins
involved in iron acquisition and transport as well as hypothetical
proteins and proteins of unknown function. The iron chelating
effect of curcuminmost likely created iron-restricted growth con-
ditions which forced the bacteria to increase expression of iron
acquisition and transport genes. Nevertheless, a large number
of genes induced in the presence of curcumin are annotated as
hypothetical and unknown function. Hence, it is possible that
these genes could be coding for virulence related factors that
contribute to the biofilm phenotype. The up-regulation of sev-
eral transcriptional regulators also points to potential indirect
effects whichmay directly or indirectly control these hypothetical
proteins.
Siderophore has been proposed as a virulence factor of B.
pseudomallei (Yang et al., 1993). Nevertheless, the induction of
siderophore gene expression upon curcumin treatment did not
lead to accelerated worm killing. On the other hand, survival of
C. elegans fed with curcumin-treated bacteria was significantly
enhanced when compared to the untreated control (Figure 6).
As curcumin chelates iron, this may have affected bacterial fit-
ness, hence, the bacteria switched their focus onto iron acqui-
sition to ensure growth and maintenance rather than infection
of the worms. The microarray analysis also showed more genes
involved in energy metabolism were induced (Figure 8), sup-
porting our observation that curcumin did not inhibit bacterial
growth. Expression of BPSS0495 (nitroreductase family protein)
and BPSS0369 (bacterioferritin ferredoxin) suggested that the
bacteria were capable of utilizing alternative metabolic pathways
for energy production.
In conclusion, we propose that curcumin is a potential anti-
infective agent against B. pseudomallei. This natural product
exerts non-favorable conditions on the bacteria’s growth, thus,
forcing the bacteria to re-focus on attaining fitness as opposed
to killing of the host. Whilst curcumin has been documented as
an anti-infective toward various pathogens, this is the first report
that demonstrates the ability of curcumin to prolong the lifespan
of the B. pseudomallei infected host. These preliminary findings
provide invaluable insight into the interaction between curcumin
and B. pseudomallei.
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